Tag: Austin Business
Zeteo Biomedical Receives US Patent for its Sublingual Delivery Device for Vaccines and Pharma
eNewsChannels NEWS: -- Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEO Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route.
2021 MHI Innovation Awards: SIERA.AI Named a Finalist for Best New Product
eNewsChannels NEWS: -- SIERA.AI, a leading innovator for safety solutions, leveraging machine vision, IoT sensors and AI technologies to prevent forklift accidents, was named a finalist in the "Best New Product" category for material handling, logistics and supply chain professionals by MHI.
Texas Department Licensing and Regulation’s (TDLR) Responsive Mold Regulation Changes Wrongly Backs Emergency Licensed Mold Remediation Efforts
eNewsChannels NEWS: -- In response to the announcement issued by Governor Abbot on February 12, 2021, in regard to the severe winter weather that caused statewide damage, the Texas Mold Assessors and Remediators Association (TMARA), the leading professional organization dedicated to protecting consumers throughout Texas, issued the following statement:
Amid Disaster Cleanup in Texas, Consumers Warned Against Unlicensed Mold Remediation Efforts
eNewsChannels NEWS: -- On February 12, 2021, Texas Governor Abbott issued a disaster declaration following the severe winter storm that caused damage statewide. Mold Inspection Sciences Texas recommends that consumers pay close attention to this announcement as it allows out-of-state and unlicensed mold assessment and remediation contractors to obtain temporary registration and to perform mold remediation and material removal on storm-damaged properties.
The Law Offices of Victoria Broussard is thankful to establish and build their client base in both Austin and Houston
eNewsChannels NEWS: -- The Law Offices of Victoria Broussard, a Houston-based law firm, today announced their return to Austin, and plans for expanding their practice across central Texas. The company launched in Austin in 2006 and relocated its office to Houston in 2014.
Pure Transplant Solutions and King’s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial
eNewsChannels NEWS: -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King's College London.
Caisson Biotech and Heparinex Announce Positive Exam Report of European Patent and the Discovery of a New Class of Sugar Polymers
eNewsChannels NEWS: -- Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings.
Safety Automation Innovator SIERA.AI Announces New Website Launch
eNewsChannels NEWS: -- SIERA.AI, a leading safety automation innovator for the material handling industry, is proud to announce the launch of its new website. The new comprehensive website reflects SIERA.AI's growth over the past few years with preventing and reducing forklift accidents with AI vision driven systems.
Kalyagen Launches ‘Stem the Tide of Time’ Campaign Featuring NBA Hall of Fame Finalist Marques Johnson
eNewsChannels NEWS: -- Kalyagen is pleased to announce the launch of its "Stem the Tide of Time" social media campaign featuring former UCLA Bruin and Milwaukee Buck All-Star Marques Johnson to promote STEMREGEN;, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).
Kalyagen Announces Clinical Trial Launch to Evaluate STEMREGEN and Stem Cells for Advanced Heart Failure Patients
eNewsChannels NEWS: -- Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the "Spanish Society of Regenerative Medicine and Cell Therapy"), is pleased to announce the launch of a multicenter clinical trial, "The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure," to evaluate the use of stem cell therapies in patients suffering from heart failure.